Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

MLA

Yonekura, Kentaro, et al. “Mogamulizumab for Adult T-Cell Leukemia-Lymphoma: A Multicenter Prospective Observational Study.” Blood Advances, vol. 4, no. 20, Oct. 2020, pp. 5133–45. EBSCOhost, https://doi.org/10.1182/bloodadvances.2020003053.

APA

Yonekura, K., Kusumoto, S., Choi, I., Nakano, N., Ito, A., Suehiro, Y., Imaizumi, Y., Yoshimitsu, M., Nosaka, K., Ohtsuka, E., Hidaka, M., Jo, T., Sasaki, H., Moriuchi, Y., Ogata, M., Tatetsu, H., Ishitsuka, K., Miyazaki, Y., Ueda, R., … Ishida, T. (2020). Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study. Blood Advances, 4(20), 5133–5145. https://doi.org/10.1182/bloodadvances.2020003053

Chicago

Yonekura, Kentaro, Shigeru Kusumoto, Ilseung Choi, Nobuaki Nakano, Asahi Ito, Youko Suehiro, Yoshitaka Imaizumi, et al. 2020. “Mogamulizumab for Adult T-Cell Leukemia-Lymphoma: A Multicenter Prospective Observational Study.” Blood Advances 4 (20): 5133–45. doi:10.1182/bloodadvances.2020003053.